Translational Research: Screening

Screening for small molecule or non-viral biologics may involve a variety of approaches at differing scales. Some examples are high throughput screening of millions of small molecules in a cellular assay, testing a few hundred FDA-approved compounds in an ex vivo culture system, or panning through a phage-display library for neutralizing peptides.

NIDDK-Specific Funding Opportunities

  • PA-16-374, Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)

Related Resources

Staff Contacts

For questions on this topic, contact Dr. Aaron Pawlyk.